Portola Pharma Investors Ink $17.5M Deal Over Stock Declines

By Emilie Ruscoe · September 20, 2022, 9:54 PM EDT

Investors in biotechnology company Portola Pharmaceuticals Inc. have asked a San Francisco federal judge to give an initial nod to a $17.5 million deal that would end claims the company failed...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Hayden v. Portola Pharmaceuticals, Inc. et al

Case Number

3:20-cv-00367

Court

California Northern

Nature of Suit

Securities/Commodities

Date Filed

January 16, 2020